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ABSTRACT
Background: Interactions between eosinophils and monocytes after lipopolysaccharide inhalation are yet to
be investigated. The mechanism of eosinophil activation induced by lipopolysaccharide in the presence of
monocytes was investigated.
Methods: Expression of ICAM-1 and Mac-1 on eosinophils was evaluated after lipopolysaccharide stimulation
in the presence of monocytes or monocyte culture supernatants. Cytokines in the supernatant of
lipopolysaccharide-stimulated monocytes were measured using a cytokine array.
Results: Expression of ICAM-1 and Mac-1 on eosinophils was up-regulated after lipopolysaccharide stimula-
tion in the presence of monocytes or monocyte culture supernatant. Lipopolysaccharide induced secretion of
ENA-78, GMCSF, GRO, IL-1beta, IL-6, IL-10, MCP-1, TNF-alpha and MIP-3 alpha from monocytes. The up-
regulation of ICAM-1, but not Mac-1, on eosinophils was attenuated by anti-TNF-alpha neutralizing antibody.
Conclusions: Monocyte-derived TNF-alpha plays an important role in the up-regulation of ICAM-I on eosino-
phils induced by lipopolysaccharides.
KEY WORDS
allergy, chronic lung disease, eosinophils, lipopolysaccharide (LPS), monocytes
INTRODUCTION
Lipopolysaccharides (LPS) inhalation exacerbates al-
lergic inflammation and is responsible for airway re-
modeling.1 Eosinophils and monocytes are included
in the major inflammatory cells that accumulate in
the inflammatory focus after LPS inhalation. It is sug-
gested that CD14 and toll-like receptor 4 (TLR4) ex-
pressed on monocytes play important roles in the
LPS-induced physiopathological response in the air-
way; however, interactions between eosinophils and
monocytes after LPS inhalation are yet to be investi-
gated. The mechanism of eosinophil activation in-
duced by LPS in the presence of monocytes was in-
vestigated in vitro using intercellular adhesion
molecule-I (ICAM-1: CD54) and Mac-1 (CD11b
CD18) expressed on eosinophils as activation mark-
ers.
METHODS
CELL PURIFICATION
Eosinophils
Peripheral blood was obtained from subjects with
mild eosinophilia. All of these subjects had never
been diagnosed with allergic diseases nor helminthic
infections and were taking no medications at the
blood sampling. Eosinophils were isolated from
heparinized venous blood using two different purifica-
tion methods. The first method was a modified CD16
negative selection method, as previously described.2
In brief, cells obtained from the buffy coat were incu-
bated with anti-CD3, anti-CD14, anti-CD16 and anti-
CD19 monoclonal antibodies (mouse IgG; Nichirei,
Tokyo, Japan), and subsequently reacted with anti-
mouse IgG magnetic beads (Dynal, Oslo, Norway).
CD3-, CD14-, CD16- and CD19-negative eosinophils
were obtained using a magnetic cell-sorting system
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(MACS; Miletenyl Biotec, Bergisch Gladbach, Ger-
many). In the second method, eosinophils were iso-
lated by sedimentation with 6% dextran, followed by
centrifugation on 1.088 Percoll (Pfizer, NY, USA)
density gradients. The cells were additionally purified
by negative selection using only anti-CD16 immu-
nomagnetic beads and MACS. Eosinophils were iso-
lated with a high purity (>97%), viability (>99%) and
yield in both methods.
Human Eosinophilic Cell Line
EoL-1 established from the peripheral blood of a pa-
tient with eosinophilic leukemia by Saito H et al.3 was
used as a human eosinophilic cell line.
Monocytes
Circulating peripheral blood mononuclear cells
(PBMC) were isolated by means of Ficol-Hypaque
separation. For depletion of T cells, NK cells, B cells,
dendritic cells and basophils from PBMC, these cells
were indirectly magnetically labeled using a cocktail
of hapten-conjugated CD3, CD7, CD19, CD45RA,
CD56 and anti-IgE antibodies and magnetic beads
coupled to an anti-hapten monoclonal antibody. The
magnetically labeled cells were depleted by MACS
system. The purity of the monocyte fractions was
more than 98% as analyzed by morphology using Diff-
Quick stain (Baxter Scientific, Florida, USA).
CELL CULTURE AND FLOW CYTOMETRIC
ANALYSIS
Eosinophils (2 × 106ml) andor monocytes (1 × 106
ml) were cultured in RPMI containing 10% fetal calf
serum with or without LPS (10 ngml) for 18 hours.
In some experiments, eosinophils (4 × 106ml × 500
μl) and monocytes (2 × 106ml × 500 μl) were cul-
tured in a well separated by Millicell HA (Millipore,
Billerica, MA, USA), a membrane with pores with a
size of 0.45 μm allowing the medium to be mixed and
isolating eosinophils in the upper chamber from
monocytes in the lower chamber. In other experi-
ments, eosinophils were cultured in 1 ml of RPMI
containing 10% fetal calf serum and 100 μl culture su-
pernatant of monocytes treated with LPS for 18
hours. Eosinophils were analyzed for their expres-
sion of ICAM-1, Mac-1, TLR4, and CD14 using a flow
cytometer (FACScan, Becton Dickinson, Cockeys-
ville, MD, USA). Monoclonal antibodies against
ICAM-1 (84H10, Beckman Coulter, MN, USA), Mac-1
(Bear-1 Nichirei, Tokyo, Japan), TLR4 (HTA125, Bec-
ton Dickinson), CD14 (CLB-Mon1, Nichirei), mouse
IgG1 (x0931, DAKO, Denmark) and mouse IgG2a
(x0943, DAKO) were used as primary antibodies.
Phycoerythrine-conjugated donkey antimouse IgG
(715-116-151, Jackson Immuno Research Laborato-
ries, Pennsylvania, USA) was used as a secondary an-
tibody. Dexamethasone (DX) was purchased from
Wako Pure Chemical Industries (Japan). Expression
of ICAM-I and Mac-1 was expressed in delta-mean
fluorescence intensity (delta-MFI), the difference in
MFI between the sample and the control.
MEASUREMENT OF CYTOKINE LEVELS IN
CELL CULTURE SUPERNATANT
The cell culture supernatants were analyzed for cy-
tokine levels by an enzyme-linked immunosorbent as-
say (ELISA, R & D Systems). And a human cytokine
antibody array (Ray Bioteck, Norcross, GA, USA),
which had epithelial neutrophil-activating protein-78,
Granulocyte-macrophage colony stimulating factor
(GMCSF), growth-related oncogene (GRO), GRO-
alpha, I-309, interleukin (IL)-1 alpha, IL-1 beta, IL-2,
IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12p40p70, IL-
13, IL-15, interferon (IFN)-gamma, monocyte chemo-
attractant protein (MCP)-1, MCP-2, MCP-3, MCP-4,
macrophage-colony stimulating factor (MCSF),
macrophage-derived chemokine (MDC), monokine
induced by gamma interferon (MIG), macrophage in-
flammatory protein (MIP)-1 beta, MIP-1 delta, MIP-3
alpha, regulated upon activation, T-cell expressed,
and presumably secreted (RANTES), stem cell factor
(SCF), stromal cell-derived factor (SDF)-1, thymus
and activation-regulated chemokine (TARC), tumor
necrosis factor (TNF)-α, TNF-β, epidermal growth
factor (EGF), insulin-like growth factor (IGF)-4, an-
giotensin, oncostatin, thrombopoietin, vascular endo-
thelial growth factor (VFGF), platelet-derived growth
factor (PDGF)-BB, leptin, brain-derived neurotrophic
factor (BDNF), B-lymphocyte chemoattractant
(BLC), Ck beta 8-1, eotaxin, eotaxin-2, eotaxin-3, fi-
broblast growth factor (FGF)-4, FGF-7, FGF-9, Fms-
like tyrosine kinase (Flt)-3 ligand, fractalkine, granu-
locyte chemotactic protein (GCP)-2, glial-derived neu-
rotrophic factor (GDNF), hematopoietic growth fac-
tor (HGF), insulin-like growth factor binding protein
(IGFBP)-1, IGFBP-2, IGFBP-3, IGFBP-4, IL-16, IP-10,
leukemia inhibitory factor (LIF), homologous to lym-
photoxins, exhibits inducible expression, and com-
petes with HSV glycoprotein D for HVEM, a receptor
expressed by T lymphocytes (LIGHT), mesoderm-
inducing factor (MIF), neutrophil activating peptides
(NAP)-2, neurotrophin (NT)-3, NT-4, osteoprotegerin,
pulmonary and activation-regulated chemokine (PARC),
placenta growth factor (PlGF), transforming growth
factor (TGF)-beta 1, TGF-beta 2, TGF-beta 3, tissue
inhibitor of metalloproteinases (TIMP)-1 and TIMP-2
on the map was utilized to know which of these cy-
tokines show apparent increase in the supernatant of
monocytes after LPS stimulation. The maps obtained
from the monocyte culture supernatants with or with-
out LPS stimulation were compared by three labora-
tory technicians without any knowledge of the map-
ping. The spots judged as newly emerged or remark-
ably enhanced with LPS stimulation were identified,
and as a consequence, the cytokines located on the
map were judged as “apparently increased”.
Eosinophil Activation and LPS
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Fig. 1 Expression of ICAM-1 and Mac-1 on eosinophils after LPS stimulation. Eosinophils cultured with monocytes 
(CD16,14 neg, Mo (＋) showed a marked increase in ICAM-1 (6790.3±1347.3%). Eol-1 and eosinophils purified using 
anti-CD16 and anti-CD14 magnetic beads (CD16,14 neg) showed no significant increase (149.9±28.7% and 142.6±
42.0%, respectively). Eosinophils purified by only CD16-negative selection (CD16 neg) also showed a significant in-
crease in ICAM-1 after LPS stimulation (380.2±80.4%) (A) (n＝7).
Expression of Mac-1 increased in eosinophils purified by only CD16-negative selection (CD16 neg; 195.3±51.2%) and 
eosinophils cultured with monocytes (CD16,14neg, Mo (＋), 232.3±35.6%). Eol-1 and eosinophils purified using anti-
CD16 and anti-CD14 magnetic beads (CD16,14 neg) showed no significant increase in Mac-1 (112.9±7.3% and 110.6±
12.8%, respectively) (B) (n＝7).
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STATISTICAL ANALYSIS
All measured values were presented as the means ±
SEs. When comparing three or more groups of data,
the Scheffe F-test was used as a post hoc test, and sig-
nificance was set at a value of less than 0.05 after
analysis of variance.
ETHICAL ASPECT
The ethical committee of the Akita University School
of Medicine approved the methods and design of this
study.
RESULTS
EXPRESSION OF ICAM-1 AND MAC-1 ON
EOSINOPHILS AFTER LPS STIMULATION
Eosinophils cultured with monocytes showed a sig-
nificant increase in ICAM-1 and Mac-1 expression. In-
terestingly, eosinophils purified by only CD16-
negative selection also showed a significant increase
in these adhesion molecules after LPS stimulation in
the absence of monocytes (Fig. 1); however, these
eosinophils expressed neither CD14 nor TRL4 before
and after the stimulation (Fig. 2). To exclude the pos-
sibility of the direct effect of LPS on the eosinophils,
eosinophils purified by CD3-, CD14-, CD16- and
CD19-negative selections and eosinophilic cell line
EoL-1 were stimulated with LPS in the absence of
monocytes. The eosinophils purified by CD3-, CD14-,
CD16- and CD19-negative selections and Eol-1
showed no increase of ICAM-1 and Mac-1 expression
(Fig. 1), which suggested that a very low percentage
of monocytes contaminating eosinophils purified by
only CD16-negative selection caused eosinophil acti-
vation following LPS stimulation.
INFLUENCE OF DIRECT EOSINOPHIL-MONO-
CYTE CONTACT ON UP-REGULATION OF
ICAM-1 AND MAC-1 ON EOSINOPHILS AFTER
LPS TREATMENT
Eosinophils mixed with monocytes and those sepa-
rated from monocytes by means of Millicell HA both
showed up-regulations of ICAM-1 and Mac-1 after
LPS treatment (Fig. 3). The up-regulatory effect of
the monocytes on the ICAM-1 expression of eosino-
phils was augmented by the direct contact of mono-
cytes and eosinophils. Furthermore, eosinophils cul-
tured in the culture supernatant of monocytes treated
with LPS showed up-regulations of ICAM-1 and Mac-
1 (Fig. 4). These results indicated that the direct con-
tact of monocytes was not essential for eosinophil ac-
tivation, and the culture supernatant of monocytes
stimulated with LPS contained an eosinophil-
activating substance(s).
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Fig. 2 Expression of CD14 and TLR4 on eosinophils. Eosinophils expressed neither CD14 nor TLR4 before (A) and af
ter (B) LPS stimulation.
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Fig. 3 Influence of direct eosinophil-monocyte contact on up-regulation of ICAM-1 and 
Mac-1 on eosinophils after LPS treatment. Eosinophils mixed with monocytes (Eo＋Mo) 
and those separated from monocytes by means of Milicel HA (Eo/Mo) showed up-regula-
tion of ICAM-1 (A; 6790.3± 1347.3 and 2723.0± 876.6%, respectively) and Mac-1 (B; 
232.3±35.6 and 225.8±46.7%, respectively) (n＝3).
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ANALYSIS OF CYTOKINES IN CULTURE SU-
PERNATANT OF MONOCYTES STIMULATED
WITH LPS
The culture supernatant of monocytes stimulated
with LPS was analyzed by a human cytokine antibody
array. Among the 79 cytokines and chemokines,
ENA-78, GMCSF, GRO, IL-1beta, IL-6, IL-10, MCP-1,
TNF-alpha and MIP-3 alpha showed an apparent in-
crease after LPS stimulation (Fig. 5).
EFFECT OF ANTI-TNF-α NEUTRALIZING ANTI-
BODY ON ICAM-1 AND MAC-1 UP-REGULATION
IN EOSINOPHILS
Eosinophils express no, or if any, negligible amount
of ligands against ENA-78 (CXCR1), GRO (CXCR2)
and MCP-1 (CCR2),4 and IL-1beta, GMCSF and IL-6
are reported to have little effect on ICAM-1 and Mac-
1 expression on eosinophils.5,6 As a possible contrib-
uting factor, TNF-alpha, which may cause up-
regulation of these adhesion molecules on human
eosinophil,7 was checked. The effect of anti-TNF-
alpha neutralizing antibody on ICAM-1 and Mac-1 up-
regulation in eosinophils induced by LPS-stimulated
Eosinophil Activation and LPS
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Fig. 4 Up-regulation of ICAM-1 and Mac-1 on eosinophils by monocyte culture super-
natant after LPS treatment. The culture supernatant of monocytes treated with LPS in-
duced up-regulation of ICAM-1 (A; 3664± 1640.7%) and Mac-1 (B; 138.2± 14.2%) on 
eosinophils (n＝8).
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Fig. 5 Analysis of cytokines in the culture supernatant of monocytes stimulated with LPS. Cytokines in the supernatant 
of monocytes cultured with (B) or without (A) LPS were detected with a human cytokine antibody aray. An aray of cyto
kines was shown on the table (C).
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Fig. 6 Efect of anti-TNF-α neutralizing antibody on ICAM-1 and Mac-1 up-regulation in 
eosinophils. Anti-TNF-alpha neutralizing antibody reduced up-regulation of ICAM-1 (A) by 89% 
and Mac-1 (B) by 37.0% (n＝3).
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monocyte culture supernatant was studied. The cul-
ture supernatants of monocytes (1 × 106 cellsml)
stimulated with LPS contained 13,800 pgml of TNF-
alpha at the highest concentration. In consequence
with the highest concentration of TNF-alpha, the final
concentration of anti-TNF-alpha neutralizing antibody
was adjusted at 200 ngml according to the manufac-
turer’s instructions. Anti-TNF-alpha neutralizing anti-
body blocked up-regulation of ICAM-1 expression on
eosinophils (Fig. 6). Mac-1 expression was also re-
duced by anti-TNF-alpha neutralizing antibody; how-
ever, there was no statistical significance and the ef-
fect was far less marked than that on ICAM-1.
EFFECT OF DEXAMETHASONE ON ICAM-1 AND
MAC-1 UP-REGURATION IN EOSINOPHILS
Purified eosinophils contaminated with 3% of mono-
cytes were stimulated with LPS under the presence
of DX at concentrations of 0, 10−9, 10−8, 10−7 and 10−6
nM for 18 hours to determine the effect of DX on the
up-regulation of ICAM-1 and Mac-1 on eosinophils.
The up-regulatory effect of LPS on expression of
ICAM-1 and Mac-1 on eosinophils in the presence of
monocytes was cancelled by DX in a dose-dependent
manner (Fig. 7).
DISCUSSION
LPS is a biologically active substance that triggers in-
flammatory reactions. The chance of inhaling this
common substantial bio-hazard is not rare. For exam-
ple, LPS is contained in cigarette smoke8 and grain
dust9,10 in the environment. Chronic inhalation of LPS
exacerbates allergic inflammation and is responsible
for remodeling of the airway.1
We measured ICAM-1 and Mac-1 as activation
markers of eosinophils after the stimulation of LPS in
this study, since these molecules trigger activation of
eosinophils such as superoxide production11 and de-
granulation.12,13 Eosinophils mixed with monocyte
showed up-regulation of ICAM-1 and Mac-1 after LPS
stimulation, and in addition, this up-regulation was
also observed without direct contact of eosinophils
with monocytes. This means that the direct contact of
eosinophils and monocytes is not essential for eosino-
phil activation, and molecules secreted by monocyte
play important roles in the activation of eosinophils af-
ter LPS stimulation. LPS augmented the secretion of
ENA-78, GMCSF, GRO, IL-1 beta, IL-6, IL-10, MCP-1,
TNF-alpha and MIP-3 alpha from monocyte. Of these
cytokines, we focused TNF-alpha which had been
proven to enhance ICAM-1 expression on human
eosinophilic leukemia Eol-1 cells.7 As expected, anti-
TNF-alpha neutralizing antibody blocked up-regula-
tion of ICAM-1 expression on eosinophils. These re-
sults suggest that TNF-alpha secreted by monocytes
plays a principal role in the up-regulation of ICAM-1
on eosinophils after LPS stimulation. Supporting our
results, recently anti-TNF-alpha therapy has been re-
ported to be a novel therapy for asthma.14 On the
other hand, Mac-1 expression was not significantly
reduced by anti-TNF-alpha neutralizing antibody. It is
possible that the other factors such as GMCSF5 play
roles in up-regulation of Mac-1 on eosinophils after
LPS stimulation. These results suggest that TNF-
alpha is, at least partly, responsible for exacerbation
of asthma.
TLR41 and CD1415,16 are known as essential com-
ponents for LPS to be biologically active; however, it
Eosinophil Activation and LPS
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Fig. 7 Efect of dexamethasone on ICAM-1 and Mac-1 up-regulation in eosinophils. The up-regulatory efect of LPS on 
expression of ICAM-1 (A) and Mac-1 (B) on eosinophils in the presence of monocytes was canceled by dexamethasone 
(DX) in a dose-dependent manner (n＝5).
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is still controversial whether LPS acts directly16,17 on
eosinophils or indirectly via TLR4- and CD14-
expressed cells, such as monocytes and macro-
phages. Previous studies demonstrated TLR4 and
CD14 mRNA in eosinophils.18,19 But, TLR4 and CD14
are yet to be proven as functioning proteins ex-
pressed on eosinophils. We failed to show TLR4 and
CD14 expression on eosinophils, which was compat-
ible with the report by Sabroe et al.20 The possibility
that the eosinophil purification procedures using anti-
body cocktails can down-regulate the expression of
CD14 or TLR4 on eosinophils was ruled out, because
we also failed to show the expression of CD14 and
TLR4 on the eosinophils analyzed by whole blood
staining method which does not require eosinophil
purification procedures (data not shown). These re-
sults indicate that eosinophils and Eol-1 express no
or, if any, undetectable levels of CD14 and TLR4, and
these cells are not activated directly by LPS. Papi A et
al. reported an increase in eosinophils, neutrophils,
RANTES, TNF-alpha, ENA-78 and ICAM-1 in the
bronchoalveolar lavage fluid of patients with exacer-
bation of chronic obstructive pulmonary disease.21
Eosinophils and monocytes, as well as neutrophils,
are included in the major inflammatory cells that ac-
cumulate in the airway after LPS inhalation. ENA-78
and GRO induce neutrophil chemotaxis. IL-1 beta
augments IL-8 production by accumulating neutro-
phils as well as resident macrophages.22 GMCSF acti-
vates neutrophils and induces release of matrix met-
alloprotease (MMP)-9.23 Thus, monocytes, eosino-
phils and neutrophils may participate in the patho-
physiology of exacerbation of chronic lung disease in-
cluding bronchial asthma caused by LPS inhalation.
Monocytes, cultured at a concentration of 1 × 106
cellsml, secreted TNF-alpha up to 13,800 pgml af-
ter LPS stimulation. This result indicates that 3% of
contaminated monocytes can produce enough
amounts of TNF-alpha to act on eosinophils in vitro,
which is compatible to the result that eosinophils pu-
rified by anti-CD16 immunomagnetic beads showed
up-regulation of ICAM-1 after LPS stimulation in spite
of their high purity.
In conclusion, activation of eosinophils by lipopoly-
saccharide-induced monocyte-derived cytokines, es-
pecially TNF-alpha, plays an important role in the
LPS-induced physiopathological response in the air-
way.
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